PATENT CLAIM ANALYSIS

Application Number: 16206390
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "254110"]

Abstract:
A method of increasing the insulin sensitivity of a mammalian cell by contacting the cell with a protein phosphatase 2A (PP2A) inhibitor having the structure (I).

Claim (Index 69):
The method of  claim 67 ,\n wherein R 4  is where R 10  is H, alkyl, alkenyl, alkynyl, aryl, substituted aryl where the substituent is other than chloro when R 1  and R 2  are \u2550O, \u2014CH 2 CN, \u2014CH 2 CO 2 R 11 , \u2014CH 2 COR 11 , \u2014NHR 11  or \u2014NH + (R 11 ) 2 ,\n where R 11  is H or alkyl; and \n each occurrence of alkyl, alkenyl, or alkynyl is branched or unbranched, unsubstituted or substituted, or a salt, enantiomer or zwitterion of the compound.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14408475', '12069147', '13866854', '14328384', '16018924']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7512632775978597
- 35 USC 102 Novelty (BERT): 0.5962101788683956
- Combined Prediction Score: 0.7357579677249133
- Mean Citation Score: 369.878716
- Max Citation Score: 506.90887
- Similarity Product: 442.12015170433466

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test